Recent EORTC and MRC UK studies: implications for imaging ovarian cancer

For many years the primary management of newly diagnosed advanced ovarian cancer has been cytoreductive surgery followed by chemotherapy, and the mainstay of follow-up of treated women has been serial assay of serum CA-125. The findings of 2 recent research protocols have a significant effect on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Spencer, John A., Perren, Timothy J.
Formato: Texto
Lenguaje:English
Publicado: e-Med 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904027/
https://www.ncbi.nlm.nih.gov/pubmed/20605760
http://dx.doi.org/10.1102/1470-7330.2010.0018
Descripción
Sumario:For many years the primary management of newly diagnosed advanced ovarian cancer has been cytoreductive surgery followed by chemotherapy, and the mainstay of follow-up of treated women has been serial assay of serum CA-125. The findings of 2 recent research protocols have a significant effect on these aspects of management.

Ejemplares similares